| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.03 |